Aequus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. The Company is engaged in the sale of dry eye products and providing promotional services to sell third-party owned products. It is developing a pipeline of products in neurology and psychiatry with a focus on addressing the need for improved medication adherence through enhanced delivery systems. It intends to commercialize its internal programs in Canada and to establish strategic partnerships to accelerate and maximize the potential of its product candidates worldwide. The Company's sales and marketing efforts are based in Canada, targeting specialized therapeutic areas, including neurology, ophthalmology and transplant. Its Ophthalmology products include Evolve Intensive Gel, Evolve Daily Intensive, and Vistitan. Its Specialty products include Tacrolimus IR and Topiramate XR.